Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related health condition is present — so a BMI just under 30 does not automatically rule you out. A prescription requires a clinical assessment regardless of your starting point, and it is a GPhC-registered prescriber, not a BMI calculator, who makes the final call. As a prescription-only medicine, Mounjaro cannot be sold or supplied legally without that prescriber involvement — which is why understanding the licensed eligibility criteria matters before you start looking for a route to treatment. If your BMI sits between 27 and 29.9 and you have a qualifying condition such as high blood pressure, high cholesterol, prediabetes, obstructive sleep apnoea or osteoarthritis, a clinical consultation is absolutely worth having.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It does, under specific conditions. The UK licence for Mounjaro covers two groups: adults with a BMI of 30 or above, and adults with a BMI of 27 or above who have at least one weight-related comorbidity. That second group is the relevant one here. Conditions that commonly qualify include type 2 diabetes, prediabetes, hypertension, dyslipidaemia (high cholesterol or triglycerides), obstructive sleep apnoea and osteoarthritis. You can read the full clinical picture in the NHS tirzepatide information page, which sets out the licensed use clearly.
One detail worth knowing: for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, UK clinical guidance recognises that health risks occur at lower BMI values, and thresholds are typically 2.5 kg/m² lower as a result. So a BMI of 27 in a white European patient and a BMI of 27 in a South Asian patient are not assessed in exactly the same way.
BMI alone never guarantees a prescription. A prescriber assesses your full health picture (current conditions, medicines, medical history, contraindications) before deciding whether treatment is clinically appropriate. If you are curious about what a low-BMI consultation typically covers, that page goes into further detail.
Mounjaro is a Prescription-Only Medicine. The only legal route is a prescription issued by a registered prescriber following a clinical assessment, full stop. No platform can legally supply it any other way. In practice, that means either your GP (though NHS access has strict phased criteria, discussed below), or a regulated private online pharmacy where a qualified prescriber reviews your case.
For a private prescription, the process at a properly regulated service looks like this: you complete a detailed health questionnaire, a GPhC-registered Independent Prescriber reviews it the same day, your identity is verified against photo ID, and your weight is confirmed on a live video call. Only then is a prescription issued and your medicine dispensed. That sequence protects you. It is also why buying Mounjaro online from a seller who skips any of those steps should be a red flag, not a selling point.
Before placing an order anywhere, spend thirty seconds checking the pharmacy's GPhC registration. The GPhC pharmacy register is publicly searchable; if a seller cannot be found there, do not order from them. nume's premises registration number is 9012878, verifiable directly on that register.
For most people with a BMI under 30, the NHS route is not currently available. NICE's appraisal of tirzepatide (TA1026) sets the NHS eligibility threshold at a BMI of 35 or above, combined with at least one qualifying weight-related condition, with phased rollout by the number of conditions present. If you want to understand what BMI you need to get Mounjaro on the NHS, that page covers the NICE criteria and ethnic-background adjustments in full, but the short version is that a BMI below 30 sits well outside the current NHS commissioning criteria.
That is not a moral judgement about who deserves treatment; it reflects how NHS commissioning is prioritised by need and budget. For people who fall outside NHS criteria, a private prescription through a regulated pharmacy is the practical alternative. The prescription is just as clinically rigorous (our prescribers follow the same licensed criteria) and there is no referral or waiting list. If you want to understand how NHS access works and whether you might qualify in future, that page explains the phased rollout timeline.
The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, including fake tirzepatide pens. In October 2025 the agency raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens; roughly 20 million doses of illegally traded weight-loss medicines have been seized in enforcement operations. Some counterfeit pens have contained entirely different substances. The risks are not theoretical.
Safe sourcing means three things: a pharmacy on the GPhC register (check it), a prescriber who actually reviews your consultation rather than auto-approving it, and medicine supplied through the licensed UK supply chain. Sellers offering these medicines without a clinical assessment, at prices far below the market, or pushing discount codes are operating outside that framework. You can report suspect sellers at the MHRA's Yellow Card site, which handles both side-effect reports and counterfeit medicine intelligence.
If the 12pm same-day dispatch cut-off matters to you (say you want your pen before the week gets away from you) that is a real feature of how nume works, but it only applies once a prescriber has reviewed and approved your case. Suitability comes first. Explore your treatment options and start a free consultation whenever you are ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.